Abstract
Platelets have a crucial role in the maintenance of hemostasis as well as in thrombosis and vessel occlusion, which underlie stroke and acute coronary syndromes. Anucleate platelets contain mRNAs and are capable of protein synthesis, raising the issue of how these mRNAs are regulated. Here we show that human platelets harbor an abundant and diverse array of microRNAs (miRNAs), which are known as key regulators of mRNA translation in other cell types. Further analyses revealed that platelets contain the Dicer and Argonaute 2 (Ago2) complexes, which function in the processing of exogenous miRNA precursors and the control of specific reporter transcripts, respectively. Detection of the receptor P2Y12 mRNA in Ago2 immunoprecipitates suggests that P2Y12 expression may be subjected to miRNA control in human platelets. Our study lends an additional level of complexity to the control of gene expression in these anucleate elements of the cardiovascular system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lee, Y. et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415–419 (2003).
Denli, A.M., Tops, B.B., Plasterk, R.H., Ketting, R.F. & Hannon, G.J. Processing of primary microRNAs by the Microprocessor complex. Nature 432, 231–235 (2004).
Gregory, R.I. et al. The Microprocessor complex mediates the genesis of microRNAs. Nature 432, 235–240 (2004).
Han, J. et al. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev. 18, 3016–3027 (2004).
Bernstein, E., Caudy, A.A., Hammond, S.M. & Hannon, G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363–366 (2001).
Provost, P. et al. Ribonuclease activity and RNA binding of recombinant human Dicer. EMBO J. 21, 5864–5874 (2002).
Zhang, H., Kolb, F.A., Jaskiewicz, L., Westhof, E. & Filipowicz, W. Single processing center models for human Dicer and bacterial RNase III. Cell 118, 57–68 (2004).
Chendrimada, T.P. et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436, 740–744 (2005).
Liu, J. et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305, 1437–1441 (2004).
Plante, I. et al. Dicer-Derived microRNAs are utilized by the fragile X mental retardation protein for assembly on target RNAs. J. Biomed. Biotechnol. 2006, 64347 (2006).
Zamore, P.D. & Haley, B. Ribo-gnome: the big world of small RNAs. Science 309, 1519–1524 (2005).
Kim, V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 6, 376–385 (2005).
Miranda, K.C. et al. A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes. Cell 126, 1203–1217 (2006).
Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004).
Ouellet, D.L., Perron, M.P., Gobeil, L.-A., Plante, P. & Provost, P. MicroRNAs in gene regulation: when the smallest governs it all. J. Biomed. Biotechnol. 2006, 69616 (2006).
Garzon, R. et al. MicroRNA fingerprints during human megakaryocytopoiesis. Proc. Natl. Acad. Sci. USA 103, 5078–5083 (2006).
Ts'ao, C.H. Rough endoplasmic reticulum and ribosomes in blood platelets. Scand. J. Haematol. 8, 134–140 (1971).
Warshaw, A.L., Laster, L. & Shulman, N.R. Protein synthesis by human platelets. J. Biol. Chem. 242, 2094–2097 (1967).
Roth, G.J., Hickey, M.J., Chung, D.W. & Hickstein, D.D. Circulating human blood platelets retain appreciable amounts of poly (A)+ RNA. Biochem. Biophys. Res. Commun. 160, 705–710 (1989).
Weyrich, A.S. et al. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc. Natl. Acad. Sci. USA 95, 5556–5561 (1998).
Evangelista, V. et al. De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin. Circ. Res. 98, 593–595 (2006).
Bugert, P., Dugrillon, A., Gunaydin, A., Eichler, H. & Kluter, H. Messenger RNA profiling of human platelets by microarray hybridization. Thromb. Haemost. 90, 738–748 (2003).
Gnatenko, D.V. et al. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 101, 2285–2293 (2003).
McRedmond, J.P. et al. Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Mol. Cell. Proteomics 3, 133–144 (2004).
Denis, M.M. et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell 122, 379–391 (2005).
Schwertz, H. et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J. Exp. Med. 203, 2433–2440 (2006).
Fink, L. et al. Characterization of platelet-specific mRNA by real-time PCR after laser-assisted microdissection. Thromb. Haemost. 90, 749–756 (2003).
Rolf, N., Knoefler, R., Suttorp, M., Kluter, H. & Bugert, P. Optimized procedure for platelet RNA profiling from blood samples with limited platelet numbers. Clin. Chem. 51, 1078–1080 (2005).
Heo, I. et al. Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol. Cell 32, 276–284 (2008).
Ouellet, D.L. et al. Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res. 36, 2353–2365 (2008).
Ameres, S.L., Martinez, J. & Schroeder, R. Molecular basis for target RNA recognition and cleavage by human RISC. Cell 130, 101–112 (2007).
Rivas, F.V. et al. Purified Argonaute2 and an siRNA form recombinant human RISC. Nat. Struct. Mol. Biol. 12, 340–349 (2005).
Beitzinger, M., Peters, L., Zhu, J.Y., Kremmer, E. & Meister, G. Identification of human microRNA targets from isolated argonaute protein complexes. RNA Biol. 4, 76–84 (2007).
Merkerova, M., Belickova, M. & Bruchova, H. Differential expression of microRNAs in hematopoietic cell lineages. Eur. J. Haematol. 81, 304–310 (2008).
Bruchova, H., Merkerova, M. & Prchal, J.T. Aberrant expression of microRNA in polycythemia vera. Haematologica 93, 1009–1016 (2008).
Dittrich, M. et al. Analysis of SAGE data in human platelets: features of the transcriptome in an anucleate cell. Thromb. Haemost. 95, 643–651 (2006).
Lai, E.C. Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat. Genet. 30, 363–364 (2002).
Hutvagner, G. & Simard, M.J. Argonaute proteins: key players in RNA silencing. Nat. Rev. Mol. Cell Biol. 9, 22–32 (2008).
Easow, G., Teleman, A.A. & Cohen, S.M. Isolation of microRNA targets by miRNP immunopurification. RNA 13, 1198–1204 (2007).
Karginov, F.V. et al. A biochemical approach to identifying microRNA targets. Proc. Natl. Acad. Sci. USA 104, 19291–19296 (2007).
Kahner, B.N., Shankar, H., Murugappan, S., Prasad, G.L. & Kunapuli, S.P. Nucleotide receptor signaling in platelets. J. Thromb. Haemost. 4, 2317–2326 (2006).
Wang, L. et al. Quantification of ADP and ATP receptor expression in human platelets. J. Thromb. Haemost. 1, 330–336 (2003).
Heijnen, H.F., Schiel, A.E., Fijnheer, R., Geuze, H.J. & Sixma, J.J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and α-granules. Blood 94, 3791–3799 (1999).
Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654–659 (2007).
Pall, G.S., Codony-Servat, C., Byrne, J., Ritchie, L. & Hamilton, A. Carbodiimide-mediated cross-linking of RNA to nylon membranes improves the detection of siRNA, miRNA and piRNA by northern blot. Nucleic Acids Res. 35, e60 (2007).
Robb, G.B., Brown, K.M., Khurana, J. & Rana, T.M. Specific and potent RNAi in the nucleus of human cells. Nat. Struct. Mol. Biol. 12, 133–137 (2005).
Acknowledgements
We thank S. Picard (Université Laval) for providing the PRP and the CHUQ Research Center Computer Graphics Department for the illustrations. M.P.P. was supported by a doctoral studentship from Natural Sciences and Engineering Research Council of Canada (NSERC). G.R. and P.P. are supported by the Fonds de la Recherche en Santé du Québec (FRSQ). This work was supported by a Cardiovascular Research Award from Pfizer Canada Inc. and a Canadian Institutes of Health Research (CIHR)/Rx&D Collaborative Research Grant (IRO-86239) to P.P.
Author information
Authors and Affiliations
Contributions
P.P. conceived and coordinated the study; P.L., G.R. and P.P. designed and planned the experiments; P.L. led the project; P.L., I.P., D.L.O. and M.P.P. performed the experiments; all authors analyzed the data and edited/commented on the manuscript; P.P. wrote the manuscript.
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–9 and Supplementary Table 1 (PDF 2711 kb)
Rights and permissions
About this article
Cite this article
Landry, P., Plante, I., Ouellet, D. et al. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol 16, 961–966 (2009). https://doi.org/10.1038/nsmb.1651
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsmb.1651
This article is cited by
-
Circulating endothelial extracellular vesicle signatures correspond with ICU requirement: an exploratory study in COVID-19 patients
Intensive Care Medicine Experimental (2023)
-
MicroRNA: Crucial modulator in purinergic signalling involved diseases
Purinergic Signalling (2023)
-
The Function and Regulation of Platelet P2Y12 Receptor
Cardiovascular Drugs and Therapy (2023)
-
Platelets from patients with visceral obesity promote colon cancer growth
Communications Biology (2022)
-
Influence of Genetic and Epigenetic Factors of P2Y12 Receptor on the Safety and Efficacy of Antiplatelet Drugs
Cardiovascular Drugs and Therapy (2022)